MEI Pharma

Yahoo Finance • 22 days ago

Let's take a look at the stocks that are in motion in today's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • 23 days ago

Top movers analysis one hour before the close of the markets on 2025-09-08: top gainers and losers in today's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT RAPP [ht... Full story

Yahoo Finance • 23 days ago

Top stock movements in today's session.

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. [topmovers] TOP GAINERS TICKER CHANGE COMMENT RAPP [https://www.chartmill.com/stock/quote/RAPP/profile] 111.0%... Full story

Yahoo Finance • 23 days ago

Let's uncover which stocks are experiencing notable gaps during today's session.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. [gap] GAP UP STOCKS TICKER CHANGE COMMENT XAIR [https://www.chartmill.com/stock/quote/XAIR/profile] 88.24%... Full story

Yahoo Finance • 23 days ago

Top movers in Monday's pre-market session

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT HOUR [https://www.ch... Full story

Yahoo Finance • 2 months ago

MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed public company to adopt Litecoin as its primary treasury reserve asset. What Happened: The acquisition, valued at... Full story

Yahoo Finance • 2 months ago

GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee

NEW YORK, United States, July 18th, 2025, Chainwire GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP) (“MEI”), in which it will serve as both strategic advis... Full story

Yahoo Finance • 2 years ago

11 Cheapest Stocks With Biggest Upside

In this piece, we will take a look at the 11 cheapest stocks with the biggest upside. If you want to skip our introduction to stock valuation and recent market news, then take a look at 5 Cheapest Stocks With Biggest Upside. Identifying t... Full story

Yahoo Finance • 2 years ago

Anson and Cable Car Send Letter to MEI Pharma Stockholders

File New Definitive Consent Materials to Remove Entire MEI Pharma Board for Cause and Add Advisory Proposal Requesting the Return of Capital to Stockholders Believe Company’s Latest Entrenchment Maneuvers Underscore Urgent Need for Board... Full story

Yahoo Finance • 2 years ago

Anson And Cable Car Send Letter to MEI Pharma Stockholders

File Definitive Consent Materials to Remove Entire MEI Pharma Board for Cause Believe Board Reconstitution is Urgently Required to Prevent the Further Destruction of Value and Ensure the Board is Acting in the Best Interest of Stockholder... Full story

Yahoo Finance • 2 years ago

MEI Pharma Postpones Special Meeting of Shareholders

SAN DIEGO, July 13, 2023--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP) (the "Company") today announced that it has postponed its special meeting in connection with the proposed transaction with Infinity Pharmaceuticals, Inc. ("Infinity... Full story

Yahoo Finance • 2 years ago

Lacklustre Performance Is Driving MEI Pharma, Inc.'s (NASDAQ:MEIP) Low P/S

MEI Pharma, Inc.'s (NASDAQ:MEIP) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy right now compared to the Biotechs industry in the United States, where around half of the companies have P/S ratios above 11.8x... Full story

Yahoo Finance • 3 years ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SUMO, MEIP

NEW YORK, Feb. 26, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 3 years ago

Lifshitz Law PLLC Announces Investigations of VBLT, HRZN, INFI, and MEIP

NEW YORK, Feb. 25, 2023 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (NASDAQ: VBLT) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of VBLT and Notable Labs, Inc. Follo... Full story

Yahoo Finance • 3 years ago

Bragar Eagel & Squire, P.C. Is Investigating Kohl’s, MEI Pharma, and TG Therapeutics and Encourages Investors to Contact the Firm

NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kohl’s Corporation (NYSE: KSS), MEI Pharma, Inc. (NASDAQ: MEIP), and... Full story

Yahoo Finance • 3 years ago

MEI Pharma Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MEI Pharma, Inc. (NASDAQ: MEIP) investors that the firm has initiated a... Full story

Yahoo Finance • 4 years ago

MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 01, 2022--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the grant of inducement stock options for an aggregate of 295,0... Full story

Yahoo Finance • 4 years ago

Revenue Downgrade: Here's What Analysts Forecast For MEI Pharma, Inc. (NASDAQ:MEIP)

Market forces rained on the parade of MEI Pharma, Inc. (NASDAQ:MEIP) shareholders today, when the analysts downgraded their forecasts for this year. Revenue estimates were cut sharply as analysts signalled a weaker outlook - perhaps a sign... Full story